Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients

Annals of Intensive Care

Table 3 Multivariable logistic regression analysis of risk factors for in-ICU mortality

	OR	95% CI	p Value
SAPS II	1.04	1.018–1.06	< 0.001
SOFA D1	1.15	1.052–1.27	0.003
Fungi	2.21	1.17–4.18	0.015
Delay in ivIgGAM administration from admission in ICU	1.006	1.003–1.009	< 0.001

ivIgGAM Intravenous IgM- and IgA-enriched immunoglobulins; ICU intensive care unit; SAPS II Simplified Acute Physiology Score; SOFA D1 sequential organ failure assessment calculated the first day of administration of ivIgGAM